Goldman Sachs’s NEVRO CORP. NVRO Stock Holding History

Goldman Sachs’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,000	Closed	-$1.62M	–	5422
2019 Q2	$1.62M	Buy	+25,000	New	+$1.56M	﹤0.01%	3671
2016 Q4	–	Sell	-75,000	Closed	-$7.83M	–	7130
2016 Q3	$7.83M	Buy	75,000 +72,500	+2,900%	+$6.55M	﹤0.01%	2654
2016 Q2	$184K	Sell	2,500 -107,600	-98%	-$7.3M	﹤0.01%	5764
2016 Q1	$6.19M	Sell	110,100 -39,600	-26%	-$2.34M	﹤0.01%	2581
2015 Q4	$10.1M	Buy	149,700 +54,700	+58%	+$2.93M	﹤0.01%	2240
2015 Q3	$4.41M	Buy	95,000 +54,500	+135%	+$2.64M	﹤0.01%	2994
2015 Q2	$2.18M	Buy	+40,500	New	+$2.06M	﹤0.01%	3754

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Goldman Sachs's NVRO Position: Q2 2025 in Review

Goldman Sachs sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 2,072,813 shares — an estimated $12.1M sold.

Goldman Sachs first reported a position in NVRO in Q4 2014 and held it in 41 quarters. The position peaked at $139M in Q1 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

Goldman Sachs reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
Goldman Sachs sold 2,072,813 NEVRO CORP. shares in Q2 2025, an estimated $12.1M.
Goldman Sachs first reported a position in NEVRO CORP. in Q4 2014 and held it in 41 quarters.
Goldman Sachs's NEVRO CORP. position peaked at $139M in Q1 2017.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.